C9 and cancer: The overall staining pattern was highly consistent between C9-C9-Bio and the two monoclonal antibodies in regard to the extent and the spatial location of the stained cancer cells, as well as negative reactivity in non-malignant cells (stromal, inflammatory, and normal epithelium), and the absence of background staining (Figs. 6A and 7A).